epigallocatechin gallate has been researched along with Anxiety in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cuerda-Ballester, M; Drehmer, E; Ibáñez, V; Lopez-Rodríguez, MM; Ortí, JER; Platero, JL; Sancho, D | 1 |
| Li, P; Qin, T; Sun, D; Wang, J; Zhang, B; Zhao, X | 1 |
| Ajit, D; Klakotskaia, D; Schachtman, TR; Serfozo, P; Simonyi, A; Sun, GY; Walker, JM; Weisman, GA; Wood, WG | 1 |
| Andrade, JP; Cardoso, A; Magano, S; Marrana, F | 1 |
| Hong, JT; Lee, MK; Lee, YM; Oh, JH; Oh, KW; Park, KS; Yoo, HS | 1 |
| Guiramand, J; Lanté, F; Maurice, T; Nedjar, M; Récasens, M; Thethi, K; Vignes, M | 1 |
1 trial(s) available for epigallocatechin gallate and Anxiety
| Article | Year |
|---|---|
The Impact of Coconut Oil and Epigallocatechin Gallate on the Levels of IL-6, Anxiety and Disability in Multiple Sclerosis Patients.
Topics: Anxiety; Biomarkers; Body Mass Index; Catechin; Coconut Oil; Diet, Mediterranean; Dietary Supplements; Disability Evaluation; Emotions; Female; Humans; Interleukin-6; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Pilot Projects; Prospective Studies; Recovery of Function; Spain; Time Factors; Treatment Outcome | 2020 |
5 other study(ies) available for epigallocatechin gallate and Anxiety
| Article | Year |
|---|---|
Protective effect of epigallocatechin-3-gallate against neuroinflammation and anxiety-like behavior in a rat model of myocardial infarction.
Topics: Animals; Anxiety; Apoptosis; Catechin; Hippocampus; Myocardial Infarction; Rats | 2020 |
Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anxiety; Catechin; Cerebral Cortex; Disease Models, Animal; Drinking Water; Female; Hippocampus; Housing, Animal; Humans; Male; Maze Learning; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Nootropic Agents; Peptide Fragments | 2015 |
D-Galactose High-Dose Administration Failed to Induce Accelerated Aging Changes in Neurogenesis, Anxiety, and Spatial Memory on Young Male Wistar Rats.
Topics: Aging; Animals; Anxiety; Body Weight; Catechin; Dentate Gyrus; Diet; Doublecortin Domain Proteins; Doublecortin Protein; Galactose; Ki-67 Antigen; Male; Maze Learning; Microtubule-Associated Proteins; Neurogenesis; Neurons; Neuropeptides; Rats, Wistar; Spatial Memory | 2015 |
(-)-Epigallocatechin-3-O-gallate (EGCG) reverses caffeine-induced anxiogenic-like effects.
Topics: Animals; Anxiety; Caffeine; Catechin; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Male; Maze Learning; Mice; Mice, Inbred ICR; Neuroprotective Agents; Rats; Rats, Wistar; Spectrum Analysis | 2010 |
Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG).
Topics: Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Behavior, Animal; Carbolines; Catechin; Cells, Cultured; Chlordiazepoxide; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Electroshock; Embryo, Mammalian; gamma-Aminobutyric Acid; Hippocampus; Male; Maze Learning; Membrane Potentials; Mice; Neurons; Patch-Clamp Techniques; Reaction Time | 2006 |